These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35272139)

  • 1. Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
    Coelho Dos Reis JGA; Ferreira GM; Lourenço AA; Ribeiro ÁL; da Mata CPDSM; de Melo Oliveira P; Marques DPA; Ferreira LL; Clarindo FA; da Silva MF; Filho HPP; Oliveira NRR; Sodré MMD; Gadelha SR; Albuquerque GR; Maciel BM; Mariano APM; Silva MM; Fontana R; Marin LJ; Carlos RSA; Lopes ATS; Ferreira FB; Dos Santos UR; Santana ÍTS; Fehlberg HF; Rezende RP; Dias JCT; Gross E; Goulart GAC; Santiago MG; de Lemos APML; da Conceição AO; Romano CC; de Carvalho LD; Martins Filho OA; Quadros CA; Morris DL; Valle SJ
    Biomed Pharmacother; 2022 Apr; 148():112753. PubMed ID: 35272139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases.
    Pillai K; Mekkawy AH; Akhter J; Morris DL
    Adv Respir Med; 2023 Apr; 91(2):146-163. PubMed ID: 37102780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming the SARS-CoV-2-mediated proinflammatory response with BromAc
    Ferreira GM; Clarindo FA; Ribeiro ÁL; Gomes-de-Pontes L; de Carvalho LD; Martins-Filho OA; da Fonseca FG; Teixeira MM; Sabino AP; Eapen MS; Morris DL; Valle SJ; Coelho-Dos-Reis JGA
    Front Immunol; 2023; 14():1308477. PubMed ID: 38193087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.
    Akhter J; Quéromès G; Pillai K; Kepenekian V; Badar S; Mekkawy AH; Frobert E; Valle SJ; Morris DL
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33800932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
    Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
    Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromelain and acetylcysteine (BromAc
    Wen HK; Valle SJ; Morris DL
    Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromelain and acetylcysteine (BromAc
    Mekkawy AH; Pillai K; Suh H; Badar S; Akhter J; Képénékian V; Ke K; Valle SJ; Morris DL
    Am J Transl Res; 2021; 13(12):13524-13539. PubMed ID: 35035694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.
    Dilly AK; Honick BD; Frederick R; Elapavaluru A; Velankar S; Makala H; Hitchens TK; Foley LM; Guo J; Beumer JH; Rigatti LH; Lee YJ; Bartlett DL; Choudry HA
    Transl Res; 2021 Mar; 229():100-114. PubMed ID: 33164812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal BromAc
    Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
    Dong L; Ke K; Badar S; Mekkawy AH; Akhter J; Pillai K; Carter CJ; Morris DL
    Am J Transl Res; 2022; 14(5):2894-2909. PubMed ID: 35702130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
    Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
    Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Mechanism of N-acetylcysteine in Treating COVID-19.
    Zhou N; Yang X; Huang A; Chen Z
    Curr Pharm Biotechnol; 2021; 22(12):1584-1590. PubMed ID: 33371832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of IL-1ra, IL-6, IL-8, MCP-1, MIP-3α, MIP-3β, and fractalkine are associated with 90-day mortality in 132 non-immunomodulated hospitalized patients with COVID-19.
    Rabøl Andersen L; Hindsberger B; Bastrup Israelsen S; Pedersen L; Bela Szecsi P; Benfield T
    PLoS One; 2024; 19(7):e0306854. PubMed ID: 38985797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.